| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| target | Chikungunya Virus reactive IgM |
| species reactivity | Chikungunya virus |
| applications | ELISA |
| assay type | Indirect & quantitative |
| available sizes | 96 tests |
Chikungunya Virus Human IgM Assay Control BC148M
$94.00
Summary
- Virion/Serion Diagnostic Kit Control for research use (RUO)
- Chikungunya Virus (CHIKV) Human IgM Assay Control, recombinant
- Applications: ELISA
- Suitable for IgM detection
- Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
- 3 mL
Chikungunya Virus Human IgM Assay Control BC148M
| kit |
|---|
| Research area Infectious Disease |
| Storage Store at 2-8°C. |
| Form liquid |
| Associated products Chikungunya Glycoprotein E2 Antigen (BA148R1) Chikungunya Glycoprotein E1 Antigen (BA148R2) Chikungunya Glycoprotein E1 (A226V) Antigen (BA148R3) Chikungunya Virus Human IgG Assay Control (BC148G) Chikungunya Virus Human IgM Assay Control (BC148M) Chikungunya Virus IgG ELISA Kit (ESR148G) Chikungunya Virus IgM ELISA Kit (ESR148M) |
| target relevance |
|---|
| Organism Chikungunya Virus |
| Protein names Chikungunyavirus |
| Structure and strains Chikungunya is an infection caused by the Chikungunya virus (CHIKV). The disease was first identified in 1952 in Tanzania and named based on the Kimakonde words for "to become contorted". Symptoms include fever and joint pain. These typically occur two to twelve days after exposure. Other symptoms may include headache, muscle pain, joint swelling, and a rash. Symptoms usually improve within a week; however, occasionally the joint pain may last for months or years. The risk of death is around 1 in 1,000. The very young, old, and those with other health problems are at risk of more severe disease. |
| Detection and diagnosis The diagnosis is mainly based on direct pathogen detection or serological methods. Within the early phases virus detection by RT-PCR is the method of choice. After the onset of immune responses viremia will drop leading to reduced sensitivity of direct detection methods. Achieving this stage demonstration of specific antibodies should be used for diagnosis. Due to persistence of IgG and to lesser extent IgM antibody serology allows for retrospective evaluation. |
Data
FAQ & Publications
Frequently Asked Questions
What is the main application of the Chikungunya Virus Human IgM Assay Control BC148M?
The Chikungunya Virus Human IgM Assay Control BC148M is primarily used as a control in ELISA assays designed for detecting human IgM antibodies against Chikungunya virus.
How should the Chikungunya Virus Human IgM Assay Control BC148M be stored to maintain its stability?
This assay control should be stored refrigerated at temperatures between 2-8°C to ensure optimal stability and performance.
Is the Chikungunya Virus Human IgM Assay Control BC148M ready to use or does it require dilution before application?
The control is provided as a ready-to-use, pre-diluted liquid suitable for direct use with SERION ELISA classic and SERION ELISA antigen assays.
What species reactivity does the Chikungunya Virus Human IgM Assay Control BC148M exhibit?
This assay control specifically targets antibodies reactive to the Chikungunya virus, making it relevant for detecting human IgM responses to this virus.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| BC148M protocol |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.